Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Too many people with viral hepatitis are diagnosed late - with dire consequences

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Many European countries 'flying blind' in their efforts to eliminate viral hepatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. NAFLD: Cardiovascular complications of NAFLD-they do matter

    Research output: Contribution to journalLetterResearchpeer-review

  4. IBD medications during pregnancy and lactation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Cirrhosis is known to cause alterations in the systemic haemodynamic system. Cirrhotic cardiomyopathy designates a cardiac dysfunction that includes impaired cardiac contractility with systolic and diastolic dysfunction, as well as electromechanical abnormalities in the absence of other known causes of cardiac disease. This condition is primarily revealed by inducing physical or pharmacological stress, but echocardiography is excellent at revealing diastolic dysfunction and might also be used to detect systolic dysfunction at rest. Furthermore, measurement of circulating levels of cardiac biomarkers could improve the diagnostic assessm+ent. Cirrhotic cardiomyopathy contributes to various complications in cirrhosis, especially as an important factor in the development of hepatic nephropathy. Additionally, cirrhotic cardiomyopathy seems to be associated with the development of heart failure in relation to invasive procedures such as shunt insertion and liver transplantation. Current pharmacological treatment is nonspecific and directed towards left ventricular failure, and liver transplantation is currently the only proven treatment with specific effect on cirrhotic cardiomyopathy.
Original languageEnglish
JournalNature reviews. Gastroenterology & hepatology
Pages (from-to)177-186
Number of pages10
Publication statusPublished - Mar 2014

ID: 41120027